Lithuanian biotech AI startup Biomatter closes $18 million Series A to scale enzyme design platform
Biomatter, a Lithuanian startup that uses AI to design custom enzymes for industrial applications, closed a $18 million Series A round led by Astanor, with participation from UVC Partners, Inventure and Metaplanet. The funding will be used to build a large R&D facility in Vilnius and expand its US commercial presence.